UIH Technologies recalled 8 units of its uCT 530 MD X-ray system on September 12, 2025. Third-party outer covers can trap between the patient table and gantry, causing mechanical interference. Healthcare providers and patients must stop using the device immediately.
Third-party outer covers can become trapped between patient table and gantry, causing mechanical interference during table movement.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact UIH Technologies LLC or your healthcare provider for instructions. Notification method: Letter
The recalled device is the Computed Tomography X-ray System, Model: uCT 530 MD. The recall affects 8 units distributed in the US and internationally. The recall was initiated on September 12, 2025.
Third-party outer covers can become trapped between the patient table and gantry. This poses a mechanical interference risk during table movement.
There are no reported injuries or incidents associated with this recall. The potential for interference presents a significant operational hazard.
Stop using the device immediately. Follow recall instructions from the manufacturer. Contact UIH Technologies LLC or your healthcare provider for further guidance.
For more information, contact UIH Technologies LLC directly. Visit their website or refer to the recall notice on the FDA website.
Get notified about recalls in categories you care about.
Bristol-Myers Squibb recalled 12,778 vials of Opdualag injection on October 21, 2025. The recall stems from a lack of assurance of sterility. The affected products were distributed nationwide in the United States.
Major Pharmaceuticals recalled Gabapentin Capsules, USP, 100 mg, on October 10, 2025, due to failed impurities specifications. The recall affects several lot numbers distributed nationwide. Consumers must stop using the affected capsules immediately.
Lannett Company, Inc. recalled 46,848 bottles of Niacin Extended-release Tablets on October 10, 2025. The recall follows reports of failed dissolution specifications, which could affect medication effectiveness. Consumers should stop using the product immediately and consult healthcare providers for guidance.